Results
eNauka >
Rezultati >
The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study
| Naziv: | The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study | Autori: | Marković, Filip; Hochmair, Maximilian; Mueser, Nino; Fabikan, Hannah; Rodriguez, Vania Mikaela; Janžič, Urška; Stjepanović, Mihailo I.   ; Kontić, Milica Đ. |
Godina: | 2025 | Publikacija: | Cancers | ISSN: | 2072-6694 Cancers Pretraži identifikator |
Izdavač: | Basel, Switzerland : MDPI | Tip rezultata: | Naučni članak | Kolacija: | vol. 17 br. 13 str. 2190 | DOI: | 10.3390/cancers17132190 | WoS-ID: | 001527119700001 | Scopus-ID: | 2-s2.0-105010622481 | PMID: | 40647488 | PMCID: | PMC12248725 | URI: | https://enauka.gov.rs/handle/123456789/990553 | URL: | https://www.mdpi.com/2072-6694/17/13/2190 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21M21 - Vodeći međunarodni časopis kategorije M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.